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Summary
Evidence to support many blood transfusion policies and
practices in sub-Saharan Africa (SSA) is weak or lacking. SSA
cannot extrapolate from wealthy countries’ research findings
because its environment, users and structures are very differ-
ent and SSA has critical blood shortages. SSA needs to gener-
ate its own evidence but research funds are very scarce and
need to be carefully targeted to match need. This study
aimed to define this need by determining research priorities
for blood services in SSA. Thirty-five stakeholders represent-
ing diverse blood services’ interests and expertise participated
in a workshop. An adapted ‘consensus development method’
was used to identify, agree and justify research priorities
under five themes through small group and plenary discus-
sion, and cumulative voting. Research priorities covered tra-
ditional research areas, such as clinical use of blood and
infection screening, but also highlighted many new, under-
researched topics, mostly concerning blood service ‘systems’,
such as economics, blood components and regulation. Lack
of electronic information management systems was an
important hindrance to the blood services’ ability to generate
robust research data. This study has identified and prioritised
novel research that will help blood services in SSA to address
their own needs including their most urgent problem: the
lack of access to adequate blood supplies. To catalyse this
research blood services in SSA need to enhance their capacity
to conduct, commission and manage research and to
strengthen their collaborations within and beyond Africa.
Keywords: blood transfusion, blood services, Africa, research.
The World Health Organization (WHO) has set out global
standards for blood transfusion services (WHO, 2016). These
state that there should be universal access to safe and effec-
tive blood and blood products for transfusion, which should
be used appropriately, and that blood donor and patient
safety should be ensured. To achieve universal access, there
must be enough blood available to meet the needs of the
population and it must be accessible to those who need it.
WHO has been committed to these standards for 40 years
and although there have been major improvements in blood
safety in sub-Saharan Africa (SSA), driven largely by the
human immunodeficiency virus (HIV) epidemic, progress in
achieving standards relating to adequate supplies and univer-
sal access, has been disappointing.
WHO recommends a clear process for producing guideli-
nes and recommendations (WHO, 2012). Some international
transfusion guidelines, particularly those relating to reducing
HIV infection risk, are based on published evidence, but, for
others (for example recommended targets for units collected/
1000 population), evidence is lacking. Policy makers and
national blood services need to understand how recommen-
dations have been derived and the strength of evidence that
supports them. This information informs transfusion
research at national level so that international guidelines can
be adapted to the national context and solutions found to
local problems.
Despite a 25% increase in the global number of blood
donations from 2004 to 2014, lethal blood shortages are still
widespread across Africa (Dzik, 2015; WHO, 2015a). For
example, a review found that 26% of women with obstetric
haemorrhage in Africa who reached hospital died because
there was no blood available (Bates et al, 2008). Mortality
among children with severe anaemia who wait more than
8 h for a transfusion is 52%; 90% of deaths occurred within
25 h of arrival in hospital (Kiguli et al, 2014). The ongoing
serious blood shortages indicate that current strategies to
provide adequate blood for transfusion in SSA are not work-
ing. Research on how to increase donations and reduce
wastage within blood banks and hospitals is urgently needed
to identify novel and context-specific solutions to the prob-
lem of blood shortages. Improving blood supplies involves
motivating new donors and retaining existing donors, max-
imising the sensitivity of infection screening while simultane-
ously minimising discards through false positivity, efficient
stock management to optimise storage and transport and
minimise outdating, and appropriate clinical use of blood.
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Many high-income countries have achieved sufficiency of
blood supplies by centralising collection, testing and distribu-
tion, using electronic records to register and recall donors,
and through electronic tracking of blood from donor to
recipient. Sophisticated haemovigilance systems, hospital
transfusion committees and specialised practitioners to over-
see appropriate clinical use of blood have also contributed.
For poorer countries in SSA these approaches may not be
feasible, affordable or even appropriate because the context
and pattern of blood donations and usage in SSA is very dif-
ferent from more wealthy regions. In SSA around 75% of
blood is used by children and pregnant women for emergen-
cies whereas 76% of blood in high-income countries is used
electively in patients over 65 years mostly for oncology and
surgery (WHO, 2015a). A substantial proportion of blood in
SSA is transfused as whole blood whereas in high-income
countries whole blood is processed into red cells, plasma and
other components and products (Loua, 2016). At least a
third of donors in SSA are family members so blood is often
donated and used within a hospital (Loua, 2016). Supersti-
tions and misperceptions surround the giving and receiving
of blood. A lack of electronic systems makes it difficult to
recall donors regularly, and to track blood units from donor
to recipient. For these reasons, blood service models and
interventions that work in high-income countries are unlikely
to be transferable to, or appropriate for, most countries in
SSA.
To address the lack of evidence from SSA to underpin
their policies and practices, blood services in SSA need to
conduct or commission research. Without a clear strategy to
guide their research priorities, there is a risk that the scarce
resources available for transfusion research will not be
focused on the region’s needs and may be unduly influenced
by the agendas of external donors. This paper describes an
inclusive and comprehensive process that identified blood
transfusion research priorities in SSA, and some initial steps
towards translating these research priorities into actions.
Materials and methods
Identifying transfusion research needs in SSA
The process for identifying transfusion research priorities was
adapted from the consensus development method for clinical
guideline development (Murphy et al, 1998). This involves
face-to-face discussions using a process that takes into
account the need to: set clear tasks and questions; carefully
select participants; structure interactions; and synthesise indi-
vidual judgements. A two-day workshop was convened in
Pretoria, South Africa for 35 participants (Appendix 1).
From our experience of a previous similar workshop, this is
a sufficient number to ensure that individual opinions are
unlikely to have undue influence on decisions, and any bias
was further reduced by incorporating a voting system (see
later). Participants had long-standing track records of
conducting, promoting or using research in SSA and
included blood service directors, researchers, clinicians, fun-
ders, policy makers, commercial organisations and non-gov-
ernmental organisations. To enhance the credibility and
widespread acceptance of the outcomes, the participants were
selected for their diverse perspectives, experiences and geo-
graphical location, and reflected the full range of key charac-
teristics of the population that would need to engage with
the new research priorities (Murphy et al, 1998).
The first meeting to identify transfusion research priorities
had been held in Mombasa in 2008 and had been attended
by several of the same participants (Mapako et al, 2008). At
that meeting participants had grouped research topics under
five themes - biological safety; blood donors; hospital use of
blood; supply and distribution; and systems and financing.
For the Pretoria workshop, participants were divided into
five groups of 6–8 people to maximise heterogeneity of
expertise and geographical location because the goal was to
explore areas of uncertainty (Murphy et al, 1998). All groups
considered each of the five research themes, and the topics
within that theme, in turn. They decided if these topics were
still relevant. They judged whether there were any new
research topics needed and if there were additional topics
that did not fall within one of the five themes.
After discussing a theme, each group presented a summary
of their discussions to all participants. Through plenary dis-
cussions, the research topics and specific research questions
associated with each research topic were refined and agreed.
These discussions produced a long list of 5–10 research ques-
tions for each theme but no indication of priority. A cumu-
lative voting system was used to provide an indication of
which research questions participants felt were most impor-
tant within each theme. The research questions were written
on a flip chart and each participant was provided with three
sticky notes, or votes, for each topic. Each participant was
asked to use all 3 of their votes and could allocate between 1
and 3 votes to those research questions they considered a
priority. Through this process an indication of the distribu-
tion of participants’ judgements, rather than just a ‘central
tendency’, could be documented (Murphy et al, 1998).
Promoting research priorities and uptake of research
results
Workshop participants brainstormed a list of funders who
may be interested in supporting blood services research. They
also considered ways of creating a community of transfusion
researchers in SSA and reducing their isolation by enhancing
their research networks. One of the most challenging aspects
of research is to ensure that the results are disseminated and
used to influence practice and policies so a session was
devoted exploring communication channels and to agreeing
actions to be taken by the participants to keep up the
momentum behind blood services research in SSA. Specific
short and medium term actions were agreed and progress on
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these in the year since the workshop was followed up
through meetings or using emails and Skype/telephone calls.
Results
Research themes and topics for SSA blood services
For each of the five themes, the research questions that
emerged as the top five priorities are presented in Tables I–V
with a synopsis of participants’ justification for each topic
given in the text. Topics introduced since 2008 (Hassall &
Bates, 2015) are indicated. The percentage of votes for these
priorities compared to the total number of votes cast for the
whole theme provide an indication of the extent of agree-
ment between participants about the importance of the five
priority topics. The total votes do not represent all votes cast
for the theme since some votes were for research questions
that were not ranked in the top five priorities.
Justifications for topics covered by research questions regarding
biological safety (Table I).
 Transfusion-relevant outbreaks: the Ebola outbreak in
west Africa posed a major challenge for the blood services,
particularly in terms of lack of knowledge, expertise and
systems for handing highly infectious samples, and for
recruiting survivors and producing convalescent plasma
 Infection screening: Over the last few years the major
knowledge gaps in infection screening have shifted
towards systems to support better testing rather than
focusing on the screening tests themselves. Research topics
therefore included comparative evaluations of combined
testing kits, of pre- versus post-donation testing strategies,
and mechanisms for establishing quality assurance systems
across the different health service tiers
 Malaria: The burden and impact of malaria in the blood
supply in SSA is poorly understood. There is no ‘gold
standard’ test for screening donor blood. More evidence
is needed about the infection risk to recipients and the
likelihood of semi-immune recipients developing malaria
from a transfusion. Estimates are needed about how rejec-
tion of malaria-positive donors may exacerbate blood
shortages, and evidence is needed so policies can be
adapted to account for differing malaria endemicities
 Bacterial contamination: This was considered to be
under-reported and under-recognised. More data are
needed to establish the prevalence, causes and clinical sig-
nificance of bacterial contamination, along with evalua-
tions of interventions to minimise risks to recipients.
 Hepatitis B virus (HBV) vaccination: Investigations into
the impact of HBV vaccination on HBV prevalence in
younger blood donors and the potential impact on blood
screening strategies are needed (new).
Justifications for topics covered by research questions regarding
blood donors and blood donation (Table II).
 Motivating and retaining donors. It is important to gain a
better understanding of how to tailor motivational messages
and recall mechanisms [e.g. Short Message Service (SMS),
social media, phone calls] for the different types of blood
donors (e.g. school children versus adults; first-time versus
repeat donors). Innovative mechanisms to promote blood
donation, such as social media, peer-motivators and incor-
porating blood transfusion information in school curricula
need evaluating (new). Better knowledge about deterrents to
becoming a first time donor, factors which contribute to
donor attrition, including during the transition period after
leaving school, and the role of parental consent (new).
 Types of blood donors. Participants recognised the need for
a more nuanced understanding of the difficulties in clearly
Table I. Biological safety.
Research question
Total votes cast
for this theme = 78
What challenges do new/emerging/epidemic
infections (e.g. Ebola) present for blood
supply/safety?
10
What is the value/relevance of existing
screening for transfusion-transmitted
infections in SSA (e.g. hepatitis C, malaria,
syphilis)?
9
What is the significance of bacterial
contamination for blood safety?
9
What is the role of pathogen inactivation
for blood safety in SSA (e.g. for malaria,
hepatitis and emerging infections)?
9
How can donor recruitment strategies be
used to increase blood safety?
9
Total 46 (56%)
SSA, sub-Saharan Africa.
Table II. Blood donors and blood donation.
Research question
Total votes
cast for this
theme = 79
How can social media be utilised to
recruit/retain blood donors?
12
Are African and Western ideas of
altruistic blood donation in conflict?
9
How can improved donor care improve
blood donation?
6
What strategies are effective in retaining
secondary school donors?
5
What incentives are appropriate/effective
in recruiting and retaining blood donors?
5
Can successful youth donor recruitment
strategies (e.g. Pledge 25) be adapted
for other donor groups?
5
Total 42 (53%)
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defining some of the different types of blood donor (i.e.
family, replacement, voluntary, repeat, regular, profes-
sional), as these may be perceived differently in Africa from
other cultures. Some of these definitions may be less impor-
tant now that more rigorous screening processes have
improved the safety of blood across all donor types.
 Donor care: Research into donor care issues, particularly
how to create a conducive donation environment, evi-
dence on the maximum frequency of blood donations
(potentially limited by anaemia and iron depletion which
is very prevalent in SSA) and optimising the care package
and follow-up for donors, remains important
 Health screening questionnaires and algorithms for
screening for transfusion-transmitted infections in SSA
are predominantly based on those used in high-income
countries. Their effectiveness needs evaluating in the con-
text of SSA because of the high prevalence of transfusion-
transmitted infections and different donor profiles (new)
 Electronic donor records: Most blood services in Africa rely
heavily on manual records, which make it difficult to follow
up and recall donors and to assess which donor recruitment
and retention strategies work in different contexts. Donor
databases are a potentially valuable resource for providing
bio-information about the general population but are cur-
rently largely paper-based. Electronic donor records and
tracking systems appropriate for SSA need to be developed
and piloted with a view to their long-term potential as a
public health resource and possibly, a bio-bank. Significant
opportunities exist for sharing such systems among coun-
tries, with potential cost-savings (new)
Justifications for topics covered by research questions regarding
hospital management of blood and blood transfusions
(Table III).
 Haemovigilance systems are almost non-existent in SSA
but are an important mechanism for improving blood
and patient safety. In SSA, where resources are limited
and reporting systems are weak, it may not be feasible to
establish and sustain a comprehensive haemovigilance sys-
tem so evidence is needed to guide targeting of resources
towards priorities. Alloimmunisation, iron overload and
post-transfusion follow-up for transfusion-transmitted
infection, particularly in patients receiving multiple trans-
fusions such as those with sickle cell disease, are particu-
larly under-researched in SSA
 Patients’ costs: Transfusion may be associated with expli-
cit and hidden costs for patients but the cost and impact
on patients and their families, and on clinical decisions,
are unknown
 Clinical use of blood: Blood is often prescribed inappro-
priately but the extent and reasons for this are not
known. Guidelines for clinical use of blood exist but the
extent of their implementation is not known. These issues
often fall under the remit of hospital transfusion commit-
tees but these committees are not common in African
hospitals. There is a need for these guidelines to be tai-
lored for use in SSA and based on evidence about the use
of blood and ancillary treatments, for conditions prevalent
in SSA. The usefulness of different haemoglobin ‘triggers’
for initiating transfusion and the role of bedside haemo-
globin measurements need to be explored.
Justifications for topics covered by research questions regarding
adequate supplies and equitable distribution (Table IV).
 Blood donation targets: National targets for blood collec-
tion need re-evaluating using up-to-date data. The targets
should be tailored for SSA and match specific needs (e.g.
to account for malaria burden). An estimate of unmet
Table III. Hospital management of blood and blood transfusions.
Research question
Total votes
cast for this
theme = 92
How can the role of hospital transfusion
committees be strengthened to ensure
adherence to guidelines?
14
How can haemovigilance systems be
implemented and sustained in SSA?
13
How does affordability and patient need
influence access to blood transfusion?
11
How can countries is SSA best develop,
disseminate and share clinical guidelines,
audits and protocols?
11
How can adherence to clinical transfusion
guidelines be monitored and improved?
9
Total 58 (63%)
SSA, sub-Saharan Africa.
Table IV. Adequate supplies and equitable distribution.
Research question
Total votes
cast for this
theme = 83
Can partnerships with commercial
organisations help to develop an
effective stock management model
for blood services in SSA?
17
What tools/data-driven models can be
used to estimate blood and blood
component requirements?
16
How much blood and blood components
do countries in SSA need and how can
this be reliably estimated?
14
What structural gaps exist between blood
banks and hospital systems that lead to
ineffective management of stocks of blood?
14
Can maximum blood order schedules
impact on blood stock management in SSA?
5
Total 66 (80%)
SSA, sub-Saharan Africa.
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need among those who do not yet access health services is
also needed.
 Blood stocks management and trends: Accurate informa-
tion about requests, blood use, ordering and distribution
and discards for blood and components and the ability to
track trends is needed in order to instigate a system of
blood ordering schedules. Current manual systems need
replacing by appropriate, and transferable, information
technology (IT) systems capable of producing data-driven
models and tools.
 Blood components: The use of blood components (e.g.
whole blood, red cells, plasma) is strongly promoted but
there is little evidence from SSA about the indications for
their use, about appropriate education for prescribers in
component use, and about how to avoid wasting plasma
due to lack of fractionation facilities (new).
Justifications for topics covered by research questions regarding
transfusion systems and sustainable financing (Table IV).
 Costs and service delivery models: The costs of the indi-
vidual components of the donor to recipient ‘vein-to-
vein’ process need to be measured for different service
delivery models (e.g. centralised, hospital-based and
hybrid systems). The applicability and replicability of vari-
ous costing models needs to be assessed from the perspec-
tives of the blood service providers, and the donors,
recipients and their families.
 Income generation: Ways of mitigating the risk of blood
services’ dependence on donor funds need to be explored,
and innovative sustainable financing mechanisms, such as
cost recovery, tax levies and commercial sector partner-
ships, tested and evaluated (new).
 Regulation of blood services: Blood is categorised as an
‘essential medicine’ so blood services in SSA are increas-
ingly subject to new regulations. These are likely to
impact on many aspects of delivery and financing of
blood services. Regulation of blood services is a new role
for regulators in Africa, so research is needed to define
the skills the regulators will need and how their role can
be used to improve, and not overburden, the blood ser-
vices (new).
 Blood service responsiveness: The recent Ebola outbreak
highlighted that blood service systems in SSA urgently
need strengthening so that they can respond rapidly to
changing needs. More evidence is needed about how to
do this effectively in different contexts and the risks and
benefits of various models. Better definitions and descrip-
tions of blood service systems, models and structures will
facilitate standard-setting, sharing of best practice among
blood services and consensus on common ‘leading’ indi-
cators which will enable within and between country
comparisons.
 Purchasing power: Potential for national or regional bulk
purchasing should be investigated to improve cost-effec-
tiveness and minimise the cost per unit of blood while
ensuring that blood services are financially sustainable
(new).
 Attracting and retaining staff: More evidence is needed
about the poorly understood factors affecting attraction,
motivation, retention and professional development, of
blood services staff in SSA and how to formalise their
career progression opportunities, as this will impact on
several aspects of the blood services, including costs and
sustainability (new).
Promoting research priorities and uptake of research
results
Financial resources to support blood services research in
SSA. Participants identified a range of funders with a repu-
tation for supporting programmes of direct or indirect rele-
vance to blood services. These included multi-national
agencies (e.g. Global Fund, European Union, Red Cross/
Crescent, World Bank), national governments and research
agencies (e.g. UK, USA, France, Japan), foundations and
trusts (e.g. Wellcome Trust, Bill and Melinda Gates Founda-
tion, Rockefeller), international blood transfusion societies,
universities, commercial and insurance companies, interna-
tional charities (e.g. Lions, Rotary) and vertical programmes
concerned with maternal and neonatal health, HIV and
malaria.
Table V. Transfusion systems and sustainable financing.
Research question
Total votes
cast for this
theme = 86
What sustainable cost-recovery models
already exist in SSA and how can
they be adopted in other countries?
22
What has been the impact on, and
sustainability of, blood safety programmes
of external financial donor input
(and withdrawal)?
17
How can blood services transition from
external donor funding (e.g. PEPFAR)
to ‘internal’ (local) funding?
12
How can the cost of production of
blood units be minimised to ensure
sustainability?
8
Can a dynamic model be developed to
determine a vein-to-vein cost
(using established models for
HIV/maternal health) of a blood
transfusion?
6
Total 65 (76%)
PEPFAR, President’s Emergency Plan for AIDS (Acquired immunod-
eficiency syndrome) Relief; SSA, sub-Saharan Africa.
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Strengthening research skills and communities. Several inno-
vative approaches were proposed for increasing the number
of researchers and volume of blood services research in SSA.
These included blood services hosting PhD students regis-
tered at local universities, promoting more in-service
research by blood service staff, advertising blood service pro-
jects for MSc and BSc students, and ensuring that blood ser-
vice issues were covered in the curricula of schools and
universities. Ideas for incentives that could be used to moti-
vate blood service staff to undertake research included educa-
tion grants for courses to learn research skills, funding
conference and workshop attendance, recognising research
activities for promotion, including research experience as a
recruitment criterion, public recognition of individuals’
research contributions through ceremonies and newsletters,
support for new researchers to develop proposals, and creat-
ing a research-conducive environment within the blood
services.
Participants recognised the importance of research for
keeping up-to-date with technology and best practice, and
for problem solving to make blood services more efficient.
However, their main priority is to provide blood for their
nation’s population and they were therefore not able to
invest a substantial proportion of their scarce resources in
research. A potential solution that emerged from discussions
was to create formal links with academic institutions. Pro-
posed mechanisms to achieve this included obtaining appro-
priate ethical and regulatory approvals for researchers to use
blood service resources (e.g. samples, donor data, test results)
to attract university researchers to work with the blood
service in exchange for blood service staff teaching in the
universities. Some blood services may also be able to host a
research office and act as a resource for research
information.
Research uptake. Uptake of research evidence to improve
services is notoriously difficult so participants made practical
suggestions about how this might be achieved in the context
of blood services in SSA. Participants understood that to
promote research uptake at national and international level
and influence changes to guidelines it was important to
understand the needs of the policy makers and regulators
and to involve them at all stages of the research process.
There are already a small number of blood transfusion
research networks in SSA, such as the Francophone Africa
Research Network and T-REC networks (Tagny et al, 2014;
Bates, 2016), that have some capacity to act as dissemination
channels and foci for research activities. Participants sug-
gested other mechanisms for promoting research uptake
including through scientific publications and through presen-
tations at, for example, grand rounds, journal clubs and sci-
entific research meetings. Opportunities for promoting more
use of evidence within individual blood services included
sharing research results with clinical collaborators, providing
training for blood service decision makers in how to critically
review evidence, establishing internal mechanisms for com-
missioning research, reviewing results and instigating evi-
dence-based change.
Short and medium term actions. Several activities were
undertaken by workshop participants in the year following
the workshop to promote the research priorities and enhance
research capacity in blood services research in SSA. The
research priorities have been disseminated through presenta-
tions at international meetings and through the websites of
the International and African Societies for Blood Transfusion
and the European Union. Research related to blood transfu-
sion in SSA and published in the last 7 years has been identi-
fied and analysed. This is being summarised for publication
and includes information on the topics researched and their
frequency, as well as an analysis of the researchers and col-
laborators, and institutions and countries involved. A data-
base of individuals involved in blood services research has
been established and is hosted and maintained by the Inter-
national Society for Blood Transfusion (ISBT) (2016). We
are aware of three grants applications that have been submit-
ted for funding, together with several student projects and
publications that all focus on priorities identified at the
workshop. Assessments of research capacity within blood ser-
vices in Ghana and Zimbabwe (Mapako et al, 2016) have
been carried out in order to guide blood services’ strategies
for strengthening their research infrastructure and creating a
research-conducive environment. The ISBT devoted their
Academy Day at the Eighth International Congress of the
African Society for Blood Transfusion in 2016 to ‘Research
and the Young Scientist’ in order to promote research
opportunities and skills among the next generation of blood
service professionals (http://www.afsbtcongress.org/).
Discussion
This study provides a comprehensive list of research topics
and questions that multi-disciplinary blood services stake-
holders across SSA have identified as their most pressing
needs. Information is provided about each topic to help
those doing and commissioning research to appreciate the
rationale behind each topic. Many of the priorities focus on
traditionally common research areas, such as clinical use of
blood and infection screening, but there is clearly a move
away from the HIV research that predominated over the last
two decades. Included in the list are some new and exciting
research topics, such as the impact of HBV vaccination on
screening strategies, culturally sensitive donor motivation
messages using social media and messaging, and novel
approaches to income generation.
It is striking that many of the major knowledge gaps con-
cern blood service ‘systems’ such as economic costs including
from the perspectives of patients and their families; blood
component need, production and use, and blood service reg-
ulation. Weak systems severely limit the ability of blood
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services in SSA to respond to challenges, such as the Ebola
epidemic, to address shortfalls in supply and to keep pace
with new developments including growing demand for blood
products for cancer care and trauma (Dzik, 2015; WHO,
2015b). Blood services research in SSA is severely hampered
by the lack of robust data concerning, for example,
haemovigilance, donor recall and blood tracking. Widespread
reliance on manual records means that blood services in SSA
do not have data about their activities and cannot demon-
strate their contribution to population health or make a
business case for investment. Recent efforts to introduce elec-
tronic blood service information systems in SSA should help
address these issues and provide a better platform for
research (https://www.jembi.org/project/blood-safety-informa
tion-system/).
During the workshop many examples of known effective
interventions were identified which are not reaching the peo-
ple or services that could benefit from them. Research into
how to implement evidence-based interventions is therefore
needed to understand how to deploy and scale up these
interventions in different contexts and to overcome health
system barriers to the delivery of policies or programmes
(Hales et al, 2016). Implementation research should be prob-
lem-focused, action-oriented and aligned with the needs of
blood services and health systems. This type of research
draws on multiple disciplines and is a collaborative endeav-
our requiring the engagement of a wide range of stakehold-
ers, including researchers, policy makers, opinion leaders,
and private and public sectors (Peters et al, 2013).
The audience for these research priorities is diverse. In
addition to blood service staff and managers in SSA, it
includes researchers, consumers of blood transfusion research
(such as policy makers, clinicians and hospital managers),
research and development funders, journal editors and con-
ference organisers. For researchers, the list of priority topics
and associated justification will help them frame their
research applications and projects so that they can provide
precise answers to fill the knowledge gaps. Having a list of
research priorities will raise awareness of the key issues
among users of research so that they can create mechanisms
to promote demand for specific research and to rapidly uti-
lise the results. Organisations that fund health research and
development can focus their grant opportunities and selec-
tion processes to ensure that the neglected research areas in
blood services are targeted for funding. Agencies that provide
a forum for disseminating research, such as academic journal
editors and conference organisers, can provide space to high-
light outputs that specifically relate to the research priorities.
A key finding of the Mombasa meeting in 2008 had been
that there was extremely limited transfusion research expertise
in SSA, both within blood services and in the wider research
community. This meant that there were almost no individuals
or institutions in SSA that could address the research gaps
identified by participants. Some early steps have been taken to
enhance the visibility of blood transfusion research in SSA, to
disseminate the research priorities and to re-orientate research
efforts towards these priorities. Since 2008 the African Society
for Blood Transfusion in collaboration with the European
Union-funded T-REC programme to enhance transfusion
research skills in SSA, has organised several workshops and
research training initiatives. These efforts have increased
research capacity in SSA’s blood services and raised awareness
among diverse stakeholders within and beyond SSA about the
importance of blood transfusion research in Africa. However
much more needs to be done to ensure that blood services in
SSA can generate and use locally-appropriate evidence to
develop, implement and update guidelines in response to their
constantly changing environment. Although blood services in
SSA should drive and own the research process, partnerships
with other African and international development communi-
ties were recognised to be essential for sharing and keeping
abreast of the latest developments. Until the essential role of
research in problem solving and challenging the status quo is
addressed, the many needless deaths due to blood shortages in
SSA will continue.
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Henrik Ullum University of Copenhagen, Denmark
Imelda Bates Liverpool School of Tropical Medicine, UK
Jean Emmanuel National Blood Service, Zimbabwe
Jessie Githanga University of Nairobi, Kenya
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Lucy Asamoah Akuoko Ghana Blood Service (Southern Area)
Lucy Marowa National Blood Service, Zimbabwe
Magdalena Lyimo Muhumbili University of Health & Allied Sciences, Tanzania
Mary Wanjiku Kariithi Africa Society for Blood Transfusion, Kenya
Nigel Talboys Terumo Corporation
Nolwazi Putuka South Africa National Blood Service
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Pete Zacharias Safe Blood for Africa Foundation
Radhi Chikwereti National Blood Service, Zimbabwe
Rene van Hulst University of Groningen, Netherlands
Selina Wallis Liverpool School of Tropical Medicine, UK
Shirley Owusu-Ofori Ghana Blood Service (Kumasi)
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Name Organisation
Susan Jones Liverpool School of Tropical Medicine, UK
Tonderai Mapako National Blood Service, Zimbabwe
Tony Cegielka Liverpool School of Tropical Medicine, UK
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